skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 25,699  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Material Type:
Article 		Add to My Research

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

The Lancet (British edition), 2019-01, Vol.393 (10166), p.31-39 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 5, 2019 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32590-X ;PMID: 30424892

Full text available

Citations Cited by
2
Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data
Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data
Material Type:
Article 		Add to My Research

Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data

The Lancet (British edition), 2018-09, Vol.392 (10151), p.929-939 [Peer Reviewed Journal]

2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Sep 15, 2018 ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31114-0 ;PMID: 30170852

Full text available

Citations Cited by
3
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Material Type:
Article 		Add to My Research

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

The Lancet (British edition), 2018-10, Vol.392 (10157), p.1519-1529 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32261-X ;PMID: 30291013

Full text available

Citations Cited by
4
The Concise Health Risk Tracking ‐ Self‐Report (CHRT‐SR)—A measure of suicidal risk: Performance in adolescent outpatients
The Concise Health Risk Tracking ‐ Self‐Report (CHRT‐SR)—A measure of suicidal risk: Performance in adolescent outpatients
Material Type:
Article 		Add to My Research

The Concise Health Risk Tracking ‐ Self‐Report (CHRT‐SR)—A measure of suicidal risk: Performance in adolescent outpatients

International journal of methods in psychiatric research, 2023-06, Vol.32 (2), p.e1944-n/a [Peer Reviewed Journal]

2022 The Authors. International Journal of Methods in Psychiatric Research published by John Wiley & Sons Ltd. ;2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1049-8931 ;EISSN: 1557-0657 ;DOI: 10.1002/mpr.1944 ;PMID: 36217566

Full text available

Citations Cited by
5
Determinants of COVID-19 disease severity in patients with cancer
Determinants of COVID-19 disease severity in patients with cancer
Material Type:
Article 		Add to My Research

Determinants of COVID-19 disease severity in patients with cancer

Nature medicine, 2020-08, Vol.26 (8), p.1218-1223 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-0979-0 ;PMID: 32581323

Full text available

Citations Cited by
6
Genetics of 35 blood and urine biomarkers in the UK Biobank
Genetics of 35 blood and urine biomarkers in the UK Biobank
Material Type:
Article 		Add to My Research

Genetics of 35 blood and urine biomarkers in the UK Biobank

Nature genetics, 2021-02, Vol.53 (2), p.185-194 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Feb 2021 ;ISSN: 1061-4036 ;EISSN: 1546-1718 ;DOI: 10.1038/s41588-020-00757-z ;PMID: 33462484

Full text available

Citations Cited by
7
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
Material Type:
Article 		Add to My Research

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

The Lancet (British edition), 2017-10, Vol.390 (10106), p.1962-1971 [Peer Reviewed Journal]

2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 28, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)32290-0 ;PMID: 28859947

Full text available

Citations Cited by
8
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
Material Type:
Article 		Add to My Research

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2018-09, Vol.392 (10152), p.1036-1046 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31924-X ;PMID: 30158069

Full text available

Citations Cited by
9
Risk of Arterial Thromboembolism in Patients With Cancer
Risk of Arterial Thromboembolism in Patients With Cancer
Material Type:
Article 		Add to My Research

Risk of Arterial Thromboembolism in Patients With Cancer

Journal of the American College of Cardiology, 2017-08, Vol.70 (8), p.926-938 [Peer Reviewed Journal]

2017 American College of Cardiology Foundation ;Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Aug 22, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.06.047 ;PMID: 28818202

Full text available

Citations Cited by
10
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
Material Type:
Article 		Add to My Research

Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study

The Lancet (British edition), 2018-08, Vol.392 (10146), p.477-486 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 11, 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31506-X ;PMID: 30129464

Full text available

Citations Cited by
11
Acute Pancreatitis: Diagnosis and Treatment
Acute Pancreatitis: Diagnosis and Treatment
Material Type:
Article 		Add to My Research

Acute Pancreatitis: Diagnosis and Treatment

Drugs (New York, N.Y.), 2022-08, Vol.82 (12), p.1251-1276 [Peer Reviewed Journal]

The Author(s) 2022 ;Copyright Springer Nature B.V. Aug 2022 ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-022-01766-4 ;PMID: 36074322

Full text available

Citations Cited by
12
Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases
Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases
Material Type:
Article 		Add to My Research

Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases

The Lancet (British edition), 2019-09, Vol.394 (10203), p.1041-1054 [Peer Reviewed Journal]

2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2019. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2019 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31674-5 ;PMID: 31443926

Full text available

Citations Cited by
13
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
Material Type:
Article 		Add to My Research

Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials

The Lancet (British edition), 2018-08, Vol.392 (10145), p.387-399 [Peer Reviewed Journal]

2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC-BY 4.0 license ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC-BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Aug 4, 2018 ;2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC-BY 4.0 license 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31133-4 ;PMID: 30017552

Full text available

Citations Cited by
14
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT
Material Type:
Article 		Add to My Research

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT

Journal of the American College of Cardiology, 2019-06, Vol.73 (22), p.2791-2802 [Peer Reviewed Journal]

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019. The Authors ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.02.032 ;PMID: 30898607

Full text available

Citations Cited by
15
Physical Activity and Mortality in Patients With Stable Coronary Heart Disease
Physical Activity and Mortality in Patients With Stable Coronary Heart Disease
Material Type:
Article 		Add to My Research

Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

Journal of the American College of Cardiology, 2017-10, Vol.70 (14), p.1689-1700 [Peer Reviewed Journal]

2017 American College of Cardiology Foundation ;Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Oct 3, 2017 ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.08.017 ;PMID: 28958324

Full text available

Citations Cited by
16
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
Material Type:
Article 		Add to My Research

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

The Lancet (British edition), 2017-06, Vol.389 (10088), p.2473-2481 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 24, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)31075-9 ;PMID: 28476288

Full text available

Citations Cited by
17
Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer
Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer
Material Type:
Article 		Add to My Research

Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer

Journal of the American College of Cardiology, 2019-06, Vol.73 (23), p.2976-2987 [Peer Reviewed Journal]

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019. The Authors ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.03.500 ;PMID: 31196455

Full text available

Citations Cited by
18
Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes
Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes
Material Type:
Article 		Add to My Research

Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes

Nature genetics, 2021-11, Vol.53 (11), p.1534-1542 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature America, Inc. ;Copyright Nature Publishing Group Nov 2021 ;ISSN: 1061-4036 ;ISSN: 1546-1718 ;EISSN: 1546-1718 ;DOI: 10.1038/s41588-021-00948-2 ;PMID: 34737425

Full text available

Citations Cited by
19
Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
Material Type:
Article 		Add to My Research

Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease

Journal of the American College of Cardiology, 2018-05, Vol.71 (21), p.2405-2414 [Peer Reviewed Journal]

2018 American College of Cardiology Foundation ;Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 29, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.03.490 ;PMID: 29793629

Full text available

Citations Cited by
20
C79 ADVANCING UNDERSTANDING OF OBSTRUCTIVE LUNG DISEASE: MEDICATIONS AND MECHANISMS OF DELIVERY: Prevalence And Characteristics Of Patients With COPD And Low Peak Inspiratory Flow Rate Recruited In A Phase 3 Development Program For Revefenacin, A Nebulized Once-Daily Long-Acting Muscarinic Antagonist
C79 ADVANCING UNDERSTANDING OF OBSTRUCTIVE LUNG DISEASE: MEDICATIONS AND MECHANISMS OF DELIVERY: Prevalence And Characteristics Of Patients With COPD And Low Peak Inspiratory Flow Rate Recruited In A Phase 3 Development Program For Revefenacin, A Nebulized Once-Daily Long-Acting Muscarinic Antagonist
Material Type:
Article 		Add to My Research

C79 ADVANCING UNDERSTANDING OF OBSTRUCTIVE LUNG DISEASE: MEDICATIONS AND MECHANISMS OF DELIVERY: Prevalence And Characteristics Of Patients With COPD And Low Peak Inspiratory Flow Rate Recruited In A Phase 3 Development Program For Revefenacin, A Nebulized Once-Daily Long-Acting Muscarinic Antagonist

American journal of respiratory and critical care medicine, 2017-01, Vol.195 [Peer Reviewed Journal]

Copyright American Thoracic Society 2017 ;ISSN: 1073-449X ;EISSN: 1535-4970

Full text available

Citations Cited by

Results 1 - 20 of 25,699  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (24,146)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1980  (27)
  2. 1980 To 1990  (202)
  3. 1991 To 2001  (495)
  4. 2002 To 2013  (2,757)
  5. After 2013  (22,229)
  6. More options open sub menu

Subject 

  1. Science & Technology  (21,159)
  2. Life Sciences & Biomedicine  (15,012)
  3. Humans  (14,672)
  4. Health Risks  (14,209)
  5. Health Risk Assessment  (13,187)
  6. Risk Factors  (10,565)
  7. Female  (10,247)
  8. Male  (9,582)
  9. Middle Aged  (8,106)
  10. Mortality  (6,812)
  11. Aged  (6,802)
  12. Science & Technology - Other Topics  (6,068)
  13. Multidisciplinary Sciences  (6,051)
  14. Adult  (6,046)
  15. Hospitals  (4,915)
  16. Medicine  (4,851)
  17. Diabetes  (4,528)
  18. Cardiovascular Disease  (4,512)
  19. Risk Analysis  (4,281)
  20. More options open sub menu

Language 

  1. English  (25,609)
  2. Japanese  (1,959)
  3. Norwegian  (51)
  4. Chinese  (35)
  5. Portuguese  (34)
  6. French  (32)
  7. German  (20)
  8. Turkish  (15)
  9. Spanish  (7)
  10. Swedish  (3)
  11. Danish  (3)
  12. Arabic  (3)
  13. Polish  (1)
  14. Italian  (1)
  15. Korean  (1)
  16. Croatian  (1)
  17. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait